Complete the Clinical Trial Biological Use Authorization (BUA) application for new and renewal projects to obtain approval for research involving recombinant DNA in human subjects. Submit Clinical Trial BUA applications at least eight weeks prior to the IBC meeting. Electronic submissions to email@example.com are preferred. Submit via campus mail to EH&S at Box 357165 or by fax to 206.221.3068.
During National Biosafety Month, you are encouraged to focus attention on biosafety policies, practices and procedures. Investigators and laboratory managers should raise biosafety awareness, discuss the importance of safety, and seek input on ways to strengthen biosafety practices and procedures in their labs. This year, EH&S is focusing on sharps safety in research and exposure response.